الأربعاء، 1 أبريل 2009

Innate Immunity

Immune Defense against Bacterial Pathogens:
Innate Immunity
Host Defense Mechanisms
Humans are in continuous associations with microorganisms, including those that readily colonize the body surfaces (see The Bacterial Flora of Humans). It is relatively rare that these microorganisms cause damage to their host. In part, this is due to the effectiveness of the host defense mechanisms, which restrict invasion by normal flora (some of which may be potential pathogens), and which defend against non-indigenous microorganisms that are overt pathogens.
The outcome of an interaction between a human host and a microbe, whether it is a component of the normal flora or an exogenous pathogen, depends on specific properties inherent to both the host and the microbe. Sometimes, the host tolerates colonization by a parasite but restricts it to regions of the body where it can do no harm (e.g. Staphylococcus aureus on the nasal membranes or Streptococcus pneumoniae in the upper respiratory tract). If the parasite invades (i.e., breaches an anatomical barrier or progresses beyond the point of colonization), an infection is said to have occurred. If, as a result of infection, pathological harm to the host becomes evident, this is called an infectious disease.
The healthy animal defends itself against pathogens different stages. The host defenses may be of such a degree that infection can be prevented entirely. Or, if infection does occur, the defenses may stop the process before disease is apparent. At other times, the defenses that are necessary to defeat a pathogen may not be effective until infectious disease is well into progress.
The host defense mechanisms are mediated by the immune system. For our purposes, the term immunity refers to the relative state of resistance of the host to infectious disease. I will adopt the nomenclature used by my colleagues at University of South Carolina School of Medicine Microbiology and Immunology On-line to draw lines between the "types of immunity", particularly as it relates to to innate immunity and adaptive immunity.
The immune system is composed of two major subdivisions, the innate or nonspecific immune system and the adaptive or specific immune system. The innate immune system is a primary defense mechanism against invading organisms, while the adaptive immune system acts as a second line of defense. Both aspects of the immune system have cellular and humoral components by which they carry out their protective functions. In addition, there is interplay between these two systems, i.e., cells or components of the innate immune system influence the adaptive immune system and vice versa. The innate and adaptive immune systems differ in several ways. The adaptive immune system requires some time to react to an invading organism, whereas the innate immune system includes defenses that, for the most part, are constitutively present and mobilized immediately upon infection. Additionally, the adaptive immune system is antigen specific and reacts only with the organism that induced the response. The innate system is not antigen specific and reacts similarly to a variety of organisms. Finally, the adaptive immune system exhibits an immunological memory. It "remembers" that it has encountered an invading organism and reacts more rapidly on subsequent exposure to the same organism. The innate immune system does not exhibit a memory response. Cellular defense. This term is used to distinguish whether an immune response is mediated by a particular type of cell, as opposed to a non cellular defense which does not involve a specifically programmed cell. As stated above, a variety of tissue cells are involved in innate and adaptive immunity, hence the term cellular defense. These include neutrophils and macrophages, which are involved in phagocytosis, basophils and mast cells, which are involved in inflammation, and B cells and T cells which account for antibody mediated immunity and cell mediated immunity, respectively.
All these cells have their origin in the bone marrow (Figure 2). Myeloid progenitor (stem) cells in the bone marrow give rise to neutrophils, eosinophils, basophils, monocytes and dendritic cells, while lymphoid progenitor (stem) cells give rise to T cells and B cells. Macrophages and dendritic cells, which play a key role in innate and adaptive immunity, are derived from monocytes; and mast cells, which are fixed in tissues, develop from the same precrusor cell as circulating basophils. B cells are produced in bone marrow and released into the blood and lymphatic systems. B-cells can develop into plasma cells that secrete antibodies. Precursor T cells undergo differentiation in the thymus into two distinct types of T cells, CD4+ T helper cells, and the CD8+ cytotoxic T cells. Macrophages and dendritic cells function as one of several bridges between innate immunity and adaptive immunity, since they present antigens to immunocompetent T-cells, which initiates an immunological response.
Figure 2. Development of cells that participate in immunity.
Innate Immunity
Innate Immunity is a form of non specific host defense against invading bacteria. It is natural or "innate" to the host, depending, in part, on genetics. Innate defense mechanisms are contitutive to the host, meaning they are continually ready to respond to invasion and do not require a period of time for induction. The most important components of innate immunity are anatomical barriers, intact normal flora, tissue bactericides including complement, and ability to undergo inflammatory and phagocytic responses.Innate immunity provides the first line of defense against invading bacteria. The skin and mucous membranes provide physical and chemical barriers to infection. The normal bacterial flora antagonize colonization of body surfaces by nonindigenous bacteria. The internal tissues invariably contain bactericidal substances. The most noteworthy antibacterial substance is the enzyme lysozyme, which is present in mucus and all bodily tissues and secretions. If these barriers are penetrated, the body contains cells that respond rapidly to the presence of the invader. These cells include macrophages and neutrophils that engulf foreign organisms and kill them. Bacterial invasion is also challenged by the activation of complement in blood and tissues and the incitement of an inflammatory process which has the tendency to focus both the innate and adaptive immune defenses on the site of invasion. Categories of Innate or Nonspecific ImmunityThe first four categories are generally considered non cellular defenses. Inflammation and Phagocytosis are forms of cellular defense.
1. Differences in susceptibility to certain pathogens2. Anatomical defense 3. Tissue bactericides, including complement4. Microbial antagonism5. Inflammation (ability to undergo an inflammatory response)6. Phagocytosis
Differences in Susceptibility of Animal Hosts to Microbial Pathogens (Natural Immunity)
Natural immunity or resistance is based on the genetics of the host. There are two aspects: (1) resistance among all members of a species, called species resistance and (2) resistance within members of the same animal species, called individual resistance.
Species resistance
Certain animals are naturally resistant or non susceptible to certain pathogens. Certain pathogens infect only humans, not lower animals, e.g. syphilis, gonorrhea, measles, poliomyelitis. On the other hand, certain pathogens (e.g. canine distemper virus) do not infect humans. Shigella infects humans and baboons but not chimpanzees. Little information is available to explain these absolute differences in susceptibility to a pathogen but it could be due to:
Absence of specific tissue or cellular receptors for attachment (colonization) by the pathogen. For example, different strains of enterotoxigenic E. coli, defined by different fimbrial antigens, colonize human infants, calves and piglets by recognizing species-specific carbohydrate receptors on enterocytes in the gastrointestinal tract.
Temperature of the host and ability of pathogen to grow. For example, birds do not normally become infected with mammalian strains of Mycobacterium tuberculosis because these strains cannot grow at the high body temperature of birds. The anthrax bacillus (Bacillus anthracis) will not grow in the cold-blooded frog (unless the frog is maintained at 37o).
Lack of the exact nutritional requirements to support the growth of the pathogen. Naturally-requiring purine-dependent strains of Salmonella typhi grow only in hosts supplying purines. Mice and rats lack this growth factor in blood and pur- strains are avirulent. By injecting purines into these animals, such that the growth factor requirement for the bacterium is satisfied, the organisms prove virulent.
Lack of a target site for a microbial toxin. Most toxins produced by bacterial cells exert their toxic activity only after binding to susceptible cells or tissues in an animal. Certain animals may lack an appropriate target cell or specific type of cell receptor for the toxin to bind to and may therefore be nonsusceptible to the activity of the toxin. For example, injection of diphtheria toxin fails to kill the rat. The unchanged toxin is excreted in the urine. If a sample of the rat urine (or pure diphtheria toxin) is injected into the guinea pig, it dies of typical lesions caused by diphtheria toxin.
Individual resistance
There are many reasons why individuals of the same animal species may exhibit greater or lesser susceptibility to the same ineffective agent.
Age. Usually this relates to the development and status of the immunological system which varies with age. It may also be associated with changes in normal flora coincidental to developmental changes in the animal.
Sex. Usually this is linked to the presence and/or development of the sex organs. For example, mastitis and infectious diseases leading to abortion will obviously occur only in the female; orchitis would occur only in males. It could also be due to anatomical structure related to sex (bladder infections are 14-times more common in females than males), and possibly the effects of sex hormones on infections.
Stress. Stress is a complex of different factors that apparently has a real influence on health. Undue exertion, shock, change in environment, climatic change, nervous or muscular fatigue, etc. are factors known to contribute to increases in susceptibility to infection. The best explanation is that in time of stress the output of cortisone from the adrenal cortex is increased. This suppresses the inflammatory processes of the host and the overall effect may be harmful. There are also a number of relationships between stress-related hormones and the functioning of the immune defenses.
Diet, malnutrition. Infections may be linked with vitamin and protein deficiencies, and this might explain partly why many infectious diseases are more prevalent and infant mortality rates are highest in parts of the world where malnourishment is a problem. Also, overfed and obese animals are more susceptible to infection. Diets high in sucrose predispose individuals to dental caries.
Intercurrent disease or trauma. The normal defenses of an animal are impaired by organic diseases such as leukemia, Hodgkin's disease, diabetes, AIDS, etc. Frequently, inflammatory or immune responses are delayed or suppressed. Colds or influenza may predispose an individual to pneumonia. Smoking tobacco predisposes to infections of the respiratory tract. Burned tissue is readily infected by Pseudomonas aeruginosa.
Therapy against other diseases. Modern therapeutic procedures used in some diseases can render an individual more susceptible to infection. Under these conditions not only pathogens, but organisms of the normal flora and nonpathogens in the host's environment, may be able to initiate infection. Examples of therapeutic procedures that reduce the efficiency of the host's defenses are treatment with corticosteroids, cytotoxic drugs, antibiotics, or irradiation.
Anatomical Defenses
The structural integrity of the body surfaces, i.e., the skin and mucous membranes, forms an effective barrier to initial lodgment or penetration by microorganisms. The skin is a very effective barrier to bacterium, so that no bacterium by itself is known to be able to penetrate unbroken skin. Of course, a puncture, cut or scrape in the skin could introduce infectious bacteria. The mucous membranes are more vulnerable to penetration by infectious bacteria but still pose a formidable barrier of mucus and antimicrobial substances.The anatomical defenses are associated with all other aspects of noncellular immunity, including individual resistance, mechanical resistance, chemical resistance and resistance established by the normal flora (Figure 3)
Figure 3. Anatomical defenses associated with tissue surfaces
Skin. The intact surface of the healthy epidermis seems to be rarely if ever penetrated by bacteria. If the integrity of the epidermis is broken (by the bite of an insect, needle stick, abrasion, cut, etc.) invasive microbes may enter. The normal flora of the skin, which metabolize substances secreted onto the skin, produce end products (e.g. fatty acids) that discourage the colonization of skin by potential pathogens. Perspiration contains lysozyme and other antimicrobial substances.
Mucous membranes. Many are heavily colonized with bacteria in whose moist secretions they survive. These normal flora are restricted from entry and usually occupy any attachment sites that might otherwise be used by pathogens. The normal flora established on mucous membranes may antagonize non-indigenous species by other means, as well. Typically, mucus contains a number of types of anti-microbial compounds, including lysozyme and secretory antibodies (IgA). Sometimes phagocytes patrol mucosal surfaces (e.g. in the lower respiratory tract). Nonetheless, most infectious agents impinge on the skin or mucous membranes of the oral cavity, respiratory tract, GI tract or urogenital tract, and from these sites most infections occur. Damage to the epithelial cells caused by toxic products of these bacteria may play a role.
Respiratory tract. Fine hairs and baffles of the nares (nasal membranes) entrap bacteria which are inhaled. Those which pass may stick to mucosal surfaces of the trachea or be swept upward by the ciliated epithelium of the lower respiratory tract. Coughing and sneezing also eliminate bacteria. The lower respiratory tract (lung) is well protected by mucus, lysozyme, secretory antibody, and phagocytosis.
Mouth, stomach and intestinal tract. Microorganisms entering by the oral route, more than any other, have to compete with the well-adapted normal flora of the mouth and intestine. Most organisms that are swallowed are destroyed by acid and various secretions of the stomach. Alkaline pH of the lower intestine can discourage other organisms. The peristaltic action of the intestine ultimately flushes out organisms which have not succeeded in colonization. Bile salts and lysozyme are present, which kill or inhibit many types of bacteria.
Urogenital Tract. The flushing mechanisms of sterile urine and the acidity of urine maintain the bladder and most of the urethra free of microorganisms. The vaginal epithelium of the female maintains a high population of Doderlein's bacillus (Lactobacillus acidophilus) whose acidic end products of metabolism (lactic acid) prevent colonization by most other types of microorganisms including potentially-pathogenic yeast (Candida albicans).
Eyes (Conjunctiva). The conjunctiva of the eye is remarkably free of most microorganisms. Blinking mechanically removes microbes, the lavaging action of tears washes the surface of the eye, and lachrymal secretions (tears) contain relatively large amounts of lysozyme.
Microbial Antagonism
This refers to the protection of the surfaces afforded by an intact normal flora in a healthy animal, and it has already been mentioned in several contexts (See The Bacterial Flora of Humans). There are three main ways that the normal flora protect the surfaces where they are colonized:
Competition with non-indigenous species for binding (colonization) sites. The normal flora are highly-adapted to the tissues of their host. That is why they are there.
Specific antagonism against non-indigenous species. Members of the normal flora may produce very specific proteins called bacteriocins which kill or inhibit other (usually closely-related) species of bacteria.
Nonspecific antagonism against non-indigenous species. The normal flora produce a variety of metabolites and end products that inhibit other microorganisms. These include fatty acids (lactate, propionate, etc.), peroxides and antibiotics.
Figure 4. Enterococcus faecalis, also classified as Streptococcus faecalis. Occasionally there is invasion of the host by the normal flora, as evidenced by this blood culture. Enterococcus faecalis, blood culture. © Gloria J. Delisle and Lewis Tomalty, Queens University Kingston, Ontario, Canada. Licensed for use by ASM Microbe Library http://www.microbelibrary.org.
Antimicrobial Substances in Host Tissues
The body fluids and organized tissues of animals naturally contain a variety of antimicrobial agent that kill or inhibit the growth of microbes. The sources and activities of a variety of host antimicrobial substances are summarized in Table 1.
TABLE 1. ANTIMICROBIAL SUBSTANCES OF HOST ORIGIN PRESENT IN BODY FLUIDS AND ORGANIZED TISSUES
Substance
Common Sources
Chemical Composition
Activity
Lysozyme
Serum, saliva, sweat, tears
Protein
Bacterial cell lysis
Complement
Serum
Protein-carbohydrate lipoprotein complex
Cell death or lysis of bacteria; participates in inflammation
Basic proteins and polypeptides (histones, ß-lysins and other cationic proteins, tissue polypeptides)
Serum or organized tissues
Proteins or basic peptides
Disruption of bacterial plasma membrane
Lactoferrin and transferrin
Body secretions, serum, organized tissue spaces
Glycoprotein
Inhibit microbial growth by binding (withholding ) iron
Peroxidase
Saliva, tissues, cells (neutrophils)
Protein
Act with peroxide to cause lethal oxidations of cells
Fibronectin
Serum and mucosal surfaces
Glycoprotein
Clearance of bacteria (opsonization)
Interferons
Virus-infected cells, lymphocytes
Protein
Resistance to virus infections
Interleukins
Macrophages, lymphocytes
Protein
Cause fever; promote activation of immune system
Complement
Complement is considered as part of the innate immunity because of its role in inflammation, phagocytosis and bacterial killing. Complement may be activated by bacterial invasion, but also by reactions between antigens and antibodies, and therefore, it may play a role in adaptive immunity, as well.
Complement is an enzymatic system of serum proteins made up of nine major components (C1 - C9) that are sequentially activated during two pathways, the classical pathway and the alternative pathway, resulting in a variety of antibacterial defenses. Complement components play a part in phagocytic chemotaxis, opsonization and the inflammatory response, and may be involved in the lysis of certain bacteria, some viruses, and other microorganisms.
Complement is activated in the classical pathway by reactions between antibodies and antigens on the surface of a microbe. Some Immunoglobulins (i.e., IgG and IgM) can "fix complement" because they have a complement binding site on the Fc portion of the molecule. The reaction between IgG and Ag activates the complement and initiates a "cascade reaction" on the surface of the microbe that results in the principal effects of complement which are:
1. Generation of inflammatory factors, C3a and C5a, which focus antimicrobial serum factors and leukocytes into the site of infection.
2. Attraction of phagocytes. Chemotactic factors C3a and C5a attract phagocytes to the site.
3. Enhancement of phagocytic engulfment. C3b component on Ag - Ab complex attaches to C3b receptors on phagocytes and promotes opsonization of Ab-coated cells. C3b-opsonization is important when Ab is IgM because phagocytes have receptors for Fc of IgM only when it is associated with C3b.
4. Lysis of bacterial cells (lysozyme-mediated) or virus-infected cells. When C8 and C9 are bound to the complex, a phospholipase is formed that destroys the membrane of Ag-bearing host cells (e.g. virus-infected cells) or the outer membrane of Gram-negative bacteria. Lysozyme gains access to peptidoglycan and completes destruction of the bacterial cell.In addition to the classical pathway of complement activation, an alternative pathway (sometimes called the "properdin pathway") of complement activation exists, which is independent of immunoglobulins. Insoluble polysaccharides (including bacterial LPS, peptidoglycan and teichoic acids) can activate complement. This allows antibody-independent activation of the complement cascade that is thought to be important in initial (pre-antibody) defense against various types of infections caused by bacteria.Figure 5. The complement cascade, precipitated by certain antigen-antibody reactions (classical pathway) or by bacterial polysaccharides (alternative pathway), leads to four principal antimicrobial effects: 1. phagocytes are attracted to the site (POLYMORPH ACCUMULATION); 2. inflammatory agents re produced and/Or released from cells (INFLAMMATION); 3. microbes are opsonized to enhance uptake by phagocytic cells (PHAGOCYTOSIS); 4. Gram-negetive bacteria are lysed in the presence of lysozyme (LYSIS OF MICROBE).
Inflammation
Of all the defense mechanisms in the animal host, the inflammatory response may be the most important for dealing with microbial infection. Inflammation is necessary for the proper functioning of all the host defenses, including the immune defenses, because it focuses all circulating antimicrobial factors on the site of infection. These include phagocytes, lymphocytes, antibodies, complement and other antimicrobial components of plasma. However, inflammation is also an important aspect of bacterial pathogenesis since the inflammatory response induced by a microbe can result in considerable damage to the host and, therefore, be part of the pathology of microbial disease.
Inflammation is a tissue reaction to infection or injury, the characteristic symptoms of which are redness, swelling, heat and pain. These are sometimes called the cardinal signs of inflammation. The redness is due to increased blood flow to the area of injury. The swelling (edema) is due to increased extravascular fluid and phagocyte infiltration to the damaged area. The heat is due to the increased blood flow and the action of pyrogens (fever-inducing agents). The pain is caused by local tissue destruction and irritation of sensory nerve receptors. If a whole organ or tissue is involved, loss of function may occur.
Inflammation can be induced by certain immunological reactions, tissue damage, or the entry of an injurious agent (microbial or nonmicrobial). Certain bacterial cells and/or their products (e.g. structural components or toxins) can induce an inflammatory response. Inflammation increases the blood supply and temperature in the inflamed tissues, which favors maximal metabolic activity of the leukocytes, and lowers the pH slightly, which tends to inhibit the multiplication of many microorganisms.
Inflammation is mediated by mast cells in fixed tissues (the GI tract, respiratory tract, conjunctiva), giving rise to a localized response; or by basophils in the blood giving rise to a systemic response. The response may be initiated in a variety of ways. Some of the main events involved in the induction and maintenance of an inflammatory response during a microbial infection are summarized below.
(1) The inflammatory response is triggered by pathogen invasion or tissue injury. Injured and dying cells release cytoplasmic constituents which lower the pH in the surrounding extracellular environment.
(2) The increased acidity activates an extracellular enzyme kallikrein which in turn activates bradykinin.
(3a) Bradykinin binds to receptors on the capillary walls opening junctions between cells to allow leakage of plasma components collectively referred to as the inflammatory exudate.
Increased capillary permeability allows leukocytes to pass from the vessels into tissues (this process is called diapedisis). The first cells to appear, and the most dominant, are neutrophils, which are actively phagocytic. The other components of the inflammatory exudate and their functions are described in Table 2 below).
(3b) Bradykinin also binds to mast cells of the connective tissue that are associated with the small vessels of most tissues. This initiates other events that are associated with the process of inflammation.
Initially, in the mast cell, there is a rapid influx of Ca++, intracellular cAMP levels drop, and mediator-rich lysosomal granules migrate to the cell surface, fuse with the cell membrane, and discharge their contents (preformed mediators of inflammation such as histamine, heparin, etc.) to the exterior by exocytosis
The change in mast cell permeability activates an enzyme, phospholipase A2 to synthesize a substance called arachidonic acid. This compound can be acted upon subsequently by the cyclooxygenase pathways or lipooxygenase pathways of the mast cell leading to new synthesis of prostaglandins, leukotrienes, and other mediators of inflammation. These substances contribute to the inflammatory exudate.
TABLE 2. FUNCTION OF COMPONENTS AND CELLS IN THE INFLAMMATORY EXUDATE
Component
Function
Bradykinin, histamine, leukotrienes, serotonin, prostaglandins
Inflammatory Agents (IA) which act on the vascular system to produce increased blood flow and permeability
Fibrin: (formed from fibrinogen in plasma)
coagulates and may localize an invading pathogen
Lysozyme
causes lysis of bacterial cell walls
Complement
various activities increase the inflammatory response and lead to increased phagocytosis and complement-mediated lysis of cells
Antibodies (in immune individuals)
block colonization by pathogens; neutralize microbial toxins or viruses; opsonize pathogens making them more susceptible to phagocytosis; activate complement
Pyrogens, including endogenous pyrogen (Interleukin 1)
cause fever acting on the thermo-regulatory control centers in the hypothalamus. (Interleukin-1, which is produced by macrophages, also promotes activation and mitosis of B-cells and T-cells)
Neutrophils
migrate to focus of infection and ingest and destroy foreign agents by phagocytosis
Macrophages
engulf and destroy infective agents, process antigenic components and convey them to lymphocytes
Immunocompetent lymphocytes (B-cells and T-cells)
for direct participation in immunological responses (AMI and CMI)
The overall effect of an inflammatory reaction is to recruit various cells and components to the actual site of microbial invasion. Many of these cells and plasma components have a direct role in defense against the intruding microorganism. These include neutrophils (phagocytes which engulf and destroy the microbes); macrophages and lymphocytes which are the cells necessary to initiate immunological responses against the pathogen; pre-existing antibodies which can neutralize microbial pathogens or their toxins; and plasma components such as lysozyme, complement and fibrin, which have a variety of antimicrobial activities.
Phagocytic Defenses
When invading parasites penetrate the tissues the inflammatory response, previously described, is immediately brought into play. Part of this response leads to the recruitment of phagocytes to the site of inflammation. Phagocytes are a class of cells which are capable of ingestion (engulfment) and destruction of microorganisms that are responsible for inciting the inflammatory response. First to accumulate around the invaders and initiate the phagocytic process are neutrophils. Later, local and blood-borne macrophages also migrate to the tissue site and initiate phagocytosis. Neutrophils (also known as polymorphonuclear leukocytes, polymorphism or Pans) and macrophages are sometimes referred to as professional phagocytes for their roles in this process.
Properties of Neutrophils
Neutrophils have their origin in multi-potential stem cells in the bone marrow. They differentiate in the marrow and are released in a mature form, containing a full complement of bactericidal agents. They are short-lived cells which constitute 30-70% of the circulating white blood cells (leukocytes).
During differentiation in the marrow (2-3 days) the nucleus of the cell becomes multilobed (hence the name polymorphonuclear leukocyte), cell division ceases, and mitochondria and endoplasm reticule disappear from the cytoplasm. At the same time the cell becomes motile and actively phagocytic. Cytoplasmic granules are formed from the Geology apparatus. These granules are called lysosomal and contain the various bactericidal and digestive enzymes which can destroy bacterial cells after engulfment. The contents of lysosomal granules include lysozyme, cationic proteins, acid hydrolyses, protease's, peroxidase and lactoferrin. Neutrophils also contain large stores of glycogen. Since they derive most of their metabolic energy from glycolysis, they can function efficiently in anaerobic environments.
Some additional properties of neutrophils are:
-Only half the neutrophils in human circulation are detectable in the blood; the rest adhere to vessel walls.
-For every circulating neutrophils, approximately 100 near mature cells are held in reserve in the bone marrow pool.
-Once a neutrophils enters the tissues, intestinal tract or respiratory tract, it never returns to the circulation.
Properties of Macrophages
Macrophages (also called mononuclear phagocytes) also arise from bone marrow stem cells which give rise to monocytes which develop into monocytes that are released into the blood stream. Monocytes make up 3-7% of the circulating white blood cells. The monocytes is actively phagocytic and bactericidal. Within 2 days or so, the blood stream monocytes (sometimes called wondering macrophages) emigrate into the tissues where they settle down, enlarge and become fixed macrophages (tissue histiocytes), which also have phagocytic potential. Macrophages are more active in phagocytosis than monocytes and develop many more granules containing hydrolytic enzymes. New macrophages can develop by cell division under inflammatory stimuli, but most macrophages are matured blood monocytes.
The total pool of macrophages is referred to as the system of mononuclear phagocytes. The system is scattered throughout connective tissue, basement membranes of small blood vessels, liver sinusoids, spleen, lung , bone marrow and lymph nodes. Monocytes from the blood migrate into virtually every organ in the body where they mature into fixed macrophages. In the lymph nodes, macrophages function as scavengers to remove foreign material from the circulation.
Compared to neutrophils, macrophages are long-lived cells. As phagocytes, neutrophils play a more important role in the acute stages of an infection, while macrophages are principally involved in chronic types of infections. Neutrophils circulate in the blood stream, and during an acute inflammatory response they migrate through the endothelial cell junctions as part of the inflammatory exudate. They migrate to the focus of the infection and ingest or phagocytose foreign agents, Neutrophils which have become engorged with bacteria usually die and largely make up the material of pus. Macrophages, which are also attracted to the area during an inflammatory response, are slower to arrive and become increasingly involved in chronic infections. They, too, are actively phagocytic and will engulf and destroy foreign particles such as bacteria. However, macrophages have another indispensable function in host defense: they "process" the antigenic components of infective agents and present them to lymphocytes, a process that may usually required for the initiation of immunological responses of the host. Macrophages and related dendritic cells are among an elite corps of antigen-presenting cells or APC's.
The Phagocytic Process
Phagocytosis and destruction of engulfed bacteria involves the following sequence of events:
1. Delivery of phagocytic cells to the site of infection
2. Phagocytic adherence to the target
3. Ingestion or engulfment of the target particle
4. Phagolysosome formation
5. Intracellular killing
6. Intracellular digestion (and egestion, in the case of macrophages)
These steps involved in the phagocytic process in macrophages are illustrated below.
Figure 6. Phagocytosis by a Macrophage. A bacterium, which may or may not be opsonized, is engulfed by the process of endocytosis. The bacterium is ingested in a membranous vesicle called the phagosome. Digestive granules (lysosomes) merge with phagosome, release their contents, and form a structure called the phagolysosome. The killing and digestion of the bacterial cell takes place in the phagolysosome. The macrophage egests debris while processing the antigenic components of the bacterium, which it returns to its surface in association with MHC II for antigen presentation to TH cells.
Delivery of phagocytic cells to the site of infection
The delivery of phagocytic cells, monocytes or neutrophils, to the site of microbial infection involves two processes:
Diapedisis: the migration of cells across vascular walls which is initiated by the mediators of inflammation (kinins, histamine, prostaglandins, etc.)
Chemotaxis. Phagocytes are motile by ameboid action. Chemotaxis is movement of the cells in response to a chemical stimulus. The eventual concentration of phagocytes at a site of injury results from chemotactic response by the phagocytes which is analogous to bacterial chemotaxis. A number of chemotactic factors (attractants) have been identified, both for neutrophils and monocytes. These include bacterial products, cell and tissue debris, and components of the inflammatory exudate such as peptides derived from complement.
Phagocytic adherence
Phagocytosis is initiated by adherence of a particle to the surface of the plasma membrane of a phagocyte. This step usually involves several types of surface receptors on the phagocyte membrane. Three major receptors on phagocytes recognize the Fc portion of IgG: one is for monomeric IgG and the others are for antigen-crosslinked IgGs. Another receptor binds a complement factor C3b. Other phagocyte receptors bind fibronectin and mannose-terminated oligosaccharides. Under certain circumstances of infection, bacteria or viruses may become coated or otherwise display on their surfaces one or another of these substances (i.e., IgG, C3b, fibronectin or mannose). Such microbes are said to be opsonized and such substances as IgG or complement C3b bound to the surface of microbes are called opsonins. (Opsonin comes from a Greek word meaning "sauce" or "seasoning": they make the microbe more palatable and more easily ingested by the phagocyte.) Opsonins provide extrinsic ligands for specific receptors on the phagocyte membrane, which dramatically increases the rate of adherence and ingestion of the pathogen. Opsonized bacteria can be cleared from the blood by phagocytes; many types of non opsonized bacteria cannot be cleared.
Less firm attachments of a phagocyte to a particle can take place in the absence of opsonization. This can be thought of as nonspecific attachment which might be due to net surface charge on the phagocyte or particle and/or hydrophobicity of the particle.
Lastly, in the absence interaction beween the phagocyte and microbe surfaces, a phenomenon called surface phagocytosis exists: a phagocyte can simply trap an organism against a surface and initiate ingestion. Surface phagocytosis may be an important pre-antibody defense mechanism which may determine whether an infection will become a disease and how severe the disease will become.
Ingestion
After attachment of the phagocyte to its target, some sort of signal generation, which is poorly understood, results in physical or chemical changes in the cell that triggers ingestion. Ingestion is an engulfment process that involves infolding or invagination of the cell membrane enclosing the particle and ultimately releasing it into the cytoplasm of the cell within a membrane vesicle. The end result of ingestion is entry of the particle enclosed in a vesicle derived from the plasma membrane of the cell. This structure is called the phagosome.
Toll-Like Receptors
Macrophages, dendritic cells, and epithelial cells have a set of transmembrane receptors that recognize different types of molecular determinants associated with both pathogenic and non pathogenic bacteria. Foremost among these are Toll-like receptors (TLRs).
In macrophages and dendritic cells, a pathogen is exposed to a TLR when it is engulfed within the phagosome membrane. Depending on which TLR it binds to will determine what the response will be. In this way, the TLRs identify the nature of the pathogen and turn on a response appropriate for dealing with it, generally by expression of various cytokines. Humans have 12 different TLRs, each of which specializes in a slightly different response to a pathogen (be it a bacterium, virus or protozoa).
For example TLR-2 binds to the peptidoglycan of Gram-positive bacteria such as streptococci and staphylococci; TLR-3 binds to double-stranded RNA; TLR-4 is activated by the lipopolysaccharide (endotoxin) in the outer membrane of Gram-negative such as Salmonella and E. coli; TLR-5 binds to the flagellin of motile bacteria like Listeria; TLR-6 forms a heterodimer with TLR-2 and responds to peptidoglycan and certain bacterial lipoproteins. TLR-7 binds to the single-stranded RNA genomes of viruses such as as influenza, mumps and measles.
In all these cases, binding of the pathogen to the TLR initiates a signaling pathway that leads to the activation of a transcription factor that turns on cytokine genes such as those for tumor necrosis factor-alpha (TNF-α), Interleukin-1 (IL-1), and chemotactic attractants that attract white blood cells to the site. These effector molecules lead to inflammation at the site. Even before these late events occur, the binding of Gram-positive bacteria to TLR-2 and Gram-negative bacteria to TLR-4 enhances phagocytosis and the fusion of the phagosomes with lysosomes.
Formation of the phagolysosome
The phagosome migrates into the cytoplasm and collides with lysosomal granules which explosively discharge their contents into the membrane-enclosed vesicle (phagosome). Membranes of the phagosome and lysosome actually fuse resulting in a digestive vacuole called the phagolysosome. Other lysosomes will fuse with the phagolysosome. It is within the phagolysosome that killing and digestion of the engulfed microbe take place. Some of the microbicidal constituents of the lysosomes of neutrophils and macrophages include lysozyme, cationic proteins, various proteases and hydrolyases and peroxidases. The killing processes are confined to the phagolysosome, such that none of the toxic substances and lethal activities of the phagocytes are turned against themselves.
Intracellular killing of organisms
After phagolysosome formation the first detectable effect on bacterial physiology, occurring within a few minutes after engulfment, is loss of viability (ability to reproduce). The exact mechanism is unknown. Inhibition of macromolecular synthesis occurs later. By 10 to 30 minutes after ingestion many pathogenic and nonpathogenic bacteria are killed followed by lysis and digestion of the bacteria by lysosomal enzymes. The microbicidal activities of phagocytes are complex and multifarious. Metabolic products, as well as lysosomal constituents, are responsible. These activities differ to some extent in neutrophils, monocytes and macrophages.
The microbicidal activities of phagocytes are usually divided into oxygen-dependent and oxygen-independent events.
Oxygen-independent activity
Lysosomal granules contain a variety of extremely basic proteins that strongly inhibit bacteria, yeasts and even some viruses. A few molecules of any one of these cationic proteins appear able to inactivate a bacterial cell by damage to their permeability barriers, but their exact modes of action are not known. The lysosomal granules of neutrophils contain lactoferrin, an extremely powerful iron-chelating protein, which withholds potential iron needed for bacterial growth. The pH of the phagolysosome may be as low as 4.0 due to accumulation of lactic acid, which is sufficiently acidic to prevent the growth of most pathogens. This acidic environment apparently optimizes the activity of many degradative lysosomal enzymes including lysozyme, glycosylases, phospholipases, and nucleases.
Oxygen-dependent activity
Liganding of Fc receptors (on neutrophils, monocytes or macrophages) and mannose receptors (on macrophages) increases their O2 uptake, called the respiratory burst. These receptors activate a membrane-bound NADPH oxidase that reduces O2 to O2- (superoxide). Superoxide can be reduced to OH. (hydroxyl radical) or dismutated to H2O2 (hydrogen peroxide) by superoxide dismutase. O2-, OH., and H2O2 are activated oxygen species that are potent oxidizing agents in biological systems which adversely affect a number of cellular structures including membranes and nucleic acids. Furthermore, at least in the case of neutrophils, these reactive oxygen intermediates can act in concert with a lysosomal enzyme called myeloperoxidase to function as the myeloperoxidase system, or MPO.
Myeloperoxidase is one of the lysosomal enzymes of neutrophils which is released into the phagocytic vacuole during fusion to form the phagolysosome. Myeloperoxidase uses H2O2 generated during the respiratory burst to catalyze halogenation (mainly chlorination) of phagocytosed microbes. Such halogenations are a potent mechanism for killing cells.
When the NADPH oxidase and myeloperoxidase systems are operating in concert, a series of reactions leading to lethal oxygenation and halogenation of engulfed microbes occurs.
Intracellular digestion
Dead microbes are rapidly degraded in phagolysosomes to low molecular-weight components. Various hydrolytic enzymes are involved including lysozyme, proteases, lipases, nucleases, and glycosylases. Neutrophils die and lyse after extended phagocytosis, killing, and digestion of bacterial cells. This makes up the characteristic properties of pus.
Macrophages egest digested debris and allow insertion of microbial antigenic components into the plasma membrane for presentation to lymphocytes in the immunological response.
Figure 7. Phagocytosis of Streptococcus pyogenes by a macrophage. CELLS alive!
Bacterial Defense Against Phagocytosis
Pathogenic bacteria have a variety of defenses against phagocytes. In fact, most successful pathogens have some mechanism(s) to contend with the phagocytic defenses of the host. These mechanisms will be discussed in detail later as part of the determinants of virulence of pathogens. However, in general, pathogens may resist phagocytosis by:
Evading phagocytes by growing in regions of the body which are not accessible to them
Avoiding engulfment by phagocytes after contact
Being able to kill phagocytes either before or after engulfment
Being able to survive inside of phagocytes (or other types of cells) and to persist as intracellular parasites

Antibiotics Production


Production of Antibiotics in an Industrial Scale

Introduction

Antibiotics are chemical substances (2ry metabolites) produced by certain microorganisms that can inhibit the growth of, and even destroy, other harmful microorganisms.
They are derived from special microorganisms or other living systems.
They are produced mainly by Actinomycetes, fungi and Bacillus.
They are produced on an industrial scale using a fermentation process.
Although the principles of antibiotic action were not discovered until the twentieth century, the first known use of antibiotics was by the Chinese over 2,500 years ago.
Today, over 10,000 antibiotic substances have been reported.
Over 8000 antibiotic substances are known most unsuitable for large scale production due to:
High toxicity.
Lack of therapeutic activity.
Can't be produced commercially (e.g. growth problems, special requirements, recovery).
Currently, antibiotics represent a multibillion dollar industry that continues to grow each year.

Background

Antibiotics are used in many forms, each of which imposes somewhat different manufacturing requirements.

For bacterial infections on the skin surface, eye, or ear, an antibiotic may be applied as an ointment or cream.
If the infection is internal, the antibiotic can be swallowed or injected directly into the body.
In these cases, the antibiotic is delivered throughout the body by absorption into the bloodstream.
Modes of action:
Antibiotics differ chemically so it is understandable that they also differ in the types of infections they cure and the ways in which they cure them.
Certain antibiotics destroy bacteria by affecting the structure of their cells.
This can occur in one of the following ways:
First, the antibiotic can weaken the cell walls of the infectious bacteria, which causes them to burst.
Second, antibiotics can cause the contents of the bacterial cells to leak out by damaging the cell membranes.
Another way in which antibiotics function is by interfering with the bacteria's metabolism.
Some antibiotics such as tetracycline and erythromycin interfere with protein synthesis.
Antibiotics like rifampin inhibit nucleic acid biosynthesis.
Still other antibiotics, such as sulfonamide or trimethoprim have a general blocking effect on cell metabolism.
The commercial development of an antibiotic is a long and costly proposal.
It begins with basic research designed to identify organisms, which produce antibiotic compounds.
During this phase, thousands of species are screened for any sign of antibacterial action.
When one is found, the species is tested against a variety of known infectious bacteria.
If the results are promising, the organism is grown on a large scale so the compound responsible for the antibiotic effect can be isolated.
This is a complex procedure because thousands of antibiotic materials have already been discovered.
Often, scientists find that their new antibiotics are not unique.
If the material passes this phase, further testing can be done. This typically involves clinical testing to prove that the antibiotic works in animals and humans and is not harmful.
If these tests are passed, the Food and Drug Administration (FDA) must then approve the antibiotic as a new drug.
This whole process can take many years.
The large-scale production of an antibiotic depends on a fermentation process.
During fermentation, large amounts of the antibiotic-producing organism are grown.
During fermentation, the organisms produce the antibiotic material, which can then be isolated for use as a drug.
For a new antibiotic to be economically feasible, manufacturers must be able to get a high yield of drug from the fermentation process, and be able to easily isolate it.
Extensive research is usually required before a new antibiotic can be commercially scaled up.

Raw Materials

The compounds that make the fermentation broth are the primary raw materials required for antibiotic production.
This broth is an aqueous solution made up of all of the ingredients necessary for the proliferation of the microorganisms.
Typically, it contains a carbon source like molasses, or soy meal, both of which are made up of lactose and glucose sugars.
These materials are needed as a food source for the organisms.
Nitrogen is another necessary compound in the metabolic cycles of the organisms. For this reason, an ammonia salt is typically used.
Additionally, trace elements needed for the proper growth of the antibiotic-producing organisms are included.
These are components such as phosphorus, sulfur, magnesium, zinc, iron, and copper introduced through water soluble salts.
To prevent foaming during fermentation, anti-foaming agents such as lard oil, octadecanol, and silicones are used.
The antibiotics are produced via secondary metabolic pathways, and originate from a small number of simple precursors, including amino acids, small fatty acids, sugars, and nucleic acids.

The Manufacturing Process

v Industrial processes involve taking advantage of normal cellular processes (e.g. fermentation, respiration) or genetic manipulating the microorganism yielding a useful or beneficial product
v In large scale production, mass culture of microorganisms can be in a variety of reactors including:
i. Controlled (computer) continuous culture fermenters (most common).
ii. Batch fermenter.
iii. Lift-tube fermenter.
iv. Solid phase bioreactor.
v. Slurry phase bioreactors: a liquid-solid mixture (e.g. 10% slurry).
vi. Fixed and fluidised bed reactors: microorganisms are present as biofilms on inert surfaces.
vii. Dialysis culture unit.
Although most antibiotics occur in nature, they are not normally available in the quantities necessary for large-scale production.
For this reason, a fermentation process was developed.
It involves:
Isolating a desired microorganism.
Fueling growth of the culture.
Refining and isolating the final antibiotic product.
It is important that sterile conditions be maintained throughout the manufacturing process, because contamination by foreign microbes will ruin the fermentation.
Scale-up:
Small laboratory scale, small vessel e.g. flask, bottle
¯
Laboratory bioreactor, e.g. fermentor (1-10 L)
¯
Pilot stage (300-3000 L)
¯
Commercial or field stage


(A) Starting the culture:

­ Before fermentation can begin, the desired antibiotic-producing organism must be isolated and its numbers must be increased by many times.
­ To do this, a starter culture from a sample of previously isolated, cold-stored organisms is created in the lab.
­ In order to grow the initial culture, a sample of the organism is transferred to an agar-containing plate.
­ The initial culture is then put into shake flasks along with food and other nutrients necessary for growth.
­ This creates a suspension, which can be transferred to seed tanks for further growth.
­ The seed tanks are steel tanks designed to provide an ideal environment for growing microorganisms.
­ They are filled with all the things the specific microorganism would need to survive and thrive, including:
i.Warm water.
ii. Carbohydrate foods like lactose or glucose sugars.
iii. Additionally, they contain other necessary carbon sources, such as acetic acid, alcohols, or hydrocarbons, and nitrogen sources like ammonia salts.
iv. Growth factors like vitamins, amino acids, and minor nutrients round out the composition of the seed tank contents.
­ The seed tanks are equipped with:
i. Mixers, which keep the growth medium moving.
ii.Pump ot deliver sterilized filtered air.
After about 24-28 hours, the material in the seed tanks is transferred to the primary fermentation tanks.

(B) Fermentation:

­ The fermentation tank is essentially a larger version of the steel, seed tank, which is able to hold about 30,000 gallons.
­ It is filled with the same growth media found in the seed tank and also provides an environment inducive to growth.
­ Here, the microorganisms are allowed to grow and multiply.
­ During this process, they excrete large quantities of the desired antibiotic.
­ The tanks are cooled to keep the temperature between 23 - 27.2 °C.
­ It is constantly agitated, and a continuous stream of sterilized air is pumped into it.
­ For this reason, anti-foaming agents are periodically added.
­ Since pH control is vital for optimal growth, acids or bases are added to the tank as necessary.


(C) Isolation and purification:

­ After three to five days, the maximum amount of antibiotic will have been produced and the isolation process can begin.
­ Depending on the specific antibiotic produced, the fermentation broth is processed by various purification methods.
­ For example:
i. For antibiotic compounds that are water soluble, an ion-exchange method may be used for purification. In this method, the compound is first separated from the waste organic materials in the broth and then sent through equipment, which separates the other water-soluble compounds from the desired one.

ii. To isolate an oil-soluble antibiotic such as penicillin, a solvent extraction method is used. In this method, the broth is treated with organic solvents such as butyl acetate or methyl isobutyl ketone, which can specifically dissolve the antibiotic. The dissolved antibiotic is then recovered using various organic chemical means.
­ At the end of this step, the manufacturer is typically left with a purified powdered form of the antibiotic, which can be further refined into different product types.

(D) Refining:

­ Antibiotic products can take on many different forms.
­ They can be sold in solutions for intravenous bags or syringes, in pill or gel capsule form, or they may be sold as powders, which are incorporated into topical ointments.
­ Depending on the final form of the antibiotic, various refining steps may be taken after the initial isolation.
i. For intravenous bags, the crystalline antibiotic can be dissolved in a solution, put in the bag, which is then hermetically sealed.
ii. For gel capsules, the powdered antibiotic is physically filled into the bottom half of a capsule then the top half is mechanically put in place.
iii. When used in topical ointments, the antibiotic is mixed into the ointment.
­ From this point, the antibiotic product is transported to the final packaging stations.
­ Here, the products are stacked and put in boxes. They are loaded up on trucks and transported to various distributors, hospitals, and pharmacies. The entire process of fermentation, recovery, and processing can take anywhere from five to eight days.


E.g.: Penicillin production

Penicillin is a b-lactam antibiotic.
It is produced commercially by the fungus Penicillium chrysogenum.
Production occurs by an aerobic process in stirred fermenters with careful adjustment of conditions.
Nutrients: the carbon source is generally lactose, ammonia or corn steep liquor is added for nitrogen and growth factors.


Since the discovery of penicillin, production has increased over 1000-fold because of:
i. Improvement and manipulations in media conditions.
ii. Isolation of a better penicillin-producing strain: Penicillium chrysogenum.
iii. Development of submerged culture technique (instead of shallow layer culturing).
iv. Selection of mutant strains: X-rays, UV light.
v. Addition of penicillin chemical building block to media: side chain precursors increase production and influence the type of penicillin produced.
vi. Improvement in recovery methods.



Quality Control

Quality control is of utmost importance in the production of antibiotics.
In the United States, antibiotic production is highly regulated by the Food and Drug Administration (FDA).
Depending on the application and type of antibiotic, more or less testing must be completed.
For example, the FDA requires that for certain antibiotics each batch must be checked by them for effectiveness and purity.
Only after they have certified the batch can it be sold for general consumption.
Since production of antibiotics involves a fermentation process, steps must be taken to ensure that absolutely no contamination is introduced at any point during production.
To do this:
a) The medium and all of the processing equipment are thoroughly steam sterilized.
b) During manufacturing, the quality of all the compounds is checked on a regular basis.
c) Frequent checks of the condition of the microorganism culture during fermentation are carried out. These are accomplished using various chromatography techniques.
d) Various physical and chemical properties of the finished product are checked such as pH, melting point, and moisture content.
e) The following must be monitored during fermentation:
i. The concentration of the product, substrate, enzymes and microorganism.
ii. Environmental factors such as OD, pressure, temperature, agitation rate.
iii. Substrate consumption, product formation and cell dried weight.

Strains used in industrial production of antibiotics:

Microorganisms used in fermentation are rarely identical to the wild type.
This is because species are often genetically modified to yield the maximum amounts of antibiotics.
Mutation is often used, and is encouraged by introducing mutagens such as ultraviolet radiation, x-rays or certain chemicals.
Selection and further reproduction of the higher yielding strains over many generations can raise yields by 20-fold or more.
Another technique used to increase yields is gene amplification, where copies of genes coding for proteins involved in the antibiotic production can be inserted back into a cell, via vectors such as plasmids.
This process must be closely linked with retesting of antibiotic production and effectiveness.

Examples of antibiotics produced by bacteria:

Antibiotics produced by Bacteria
Antibiotic Bacterial Species
Tetracycline Streptomyces remosus
Streptomycin Streptomyces griseus
Cyclohexamide Streptomyces griseus
Neomycin Streptomyces frodiae
Cycloserine Streptomyces orchidaceus
Erythromycin Streptomyces erythreus
Kanamycin Streptomyces kanamyceticus
Lincomycin Streptomyces lincolnensis
Nystatin Streptomyces noursei
Polymyxin B Bacillus polymyxa
Bacitracin Bacillus licheniformis

























Properties of an industrial microorganism:

1. Genetically stable.
2. Suitable for scale-up.
3. Easily grown.
4. Rapid growth rate.
5. Grown on relatively cheap media or waste materials: molasses, bagasse, corn steep liquor, whey, cassava, yam, potatoes, grapes…etc.
6. Amenable to genetic manipulation (mutation and selection).

The Future

Since the development of a new drug is a costly proposition, pharmaceutical companies have done very little research in the last decade.
However, an alarming development has spurred a revived interest in the development of new antibiotics.
It turns out that some of the disease-causing bacteria have mutated and developed a resistance to many of the standard antibiotics.
This could have grave consequences on the world's public health unless new antibiotics are discovered or improvements are made on the ones that are available.
This challenging problem will be the focus of research for many years to come.

الجمعة، 27 مارس 2009

Rickettsias



Rickesias

Scientific classification
Kingdom:
Bacteria
Phylum:
Proteobacteria
Class:
Alpha Proteobacteria
Order:
Rickettsiales
Family:
Rickettsiaceae
Genus:
Rickettsia
Species
Rickettsia felis , Rickettsia prowazekii , Rickettsia rickettsii , Rickettsia typhi Rickettsia conorii , Rickettsia africae




General Features:
· The rickettsia are bacteria which are obligate intracellular parasites.
· . They are considered a separate group of bacteria Because they have the common feature of being spread by arthropod vectors (lice, fleas, mites and ticks). that may transmit the organism to mammalian hosts.
· The cells are extremely small (0.25 u in diameter) rod-shaped, coccoid and often pleomorphic microorganisms which have typical bacterial cell walls.
· No flagella (except for Rickettsia prowazekii), gram-negative and multiply by binary fission only inside host cells, Coxiella replicate only in the phagolysosome.
· They occur singly, in pairs, or in strands.
· Most species are found only in the cytoplasm of host cells, but those which cause spotted fevers multiply in nuclei as well as in cytoplasm.
· In the laboratory, they may be cultivated in living tissues such as embryonated chicken eggs or vertebrate cell cultures.
· The rickettsiae have very small genomes of about 1.0-1.5 million bases.

· The family Rickettsiaceae is taxonomically divided into three genera:
1. Rickettsia (11 species):
obligate intracellular parasites which do not multiply in vacuoles and do not parasitize white blood cells.

2. Ehrlichia (2 species):
Obligate intracellular parasites which do not multiply in vacuoles but do parasitize white blood cells.
3. Coxiella (1 species):
Obligate intracellular parasite which grows preferentially in vacuoles of host cells.
4. Baartonella (3 species):
Intracellular parasite which attacks the red blood cells.


Structure:
· The structure of the typical rickettsia is very similar to that of Gram-negative bacteria.
· The typical envelope consists of three major layers:
ü An innermost cytoplasmic membrane.
ü Athin electron dense rigid cell wall and an outer layer.
· The outer layer resembles typical membranes in its chemical composition and its trilaminar appearance.
· The cell wall is chemically similar to that of Gram-negative bacteria in that it contains diamino pimelic acid and lacks teichoic acid.
· There are no discrete nuclear structures.
· The flagellum of R. prowazekii is similar to that of other bacteria.

Metabolism:

In dilute buffered salt solutions:
· isolated rickettsia are unstable, losing metabolic activity & infectivity for animal cells.
· If however, the medium is enriched with potassium, serum albumin and sucrose, the isolated organisms can survive for many hours.
· If ATP is added to the solution, the organisms metabolize and consume oxygen.
· The basis for the obligate parasitism of these cells is that they require the rich cytoplasm to stabilize an unusually permeable cell membrane.
· The rickettsia have many of the metabolic capabilities of bacteria, but require an exogenous supply of cofactors to express these capabilities. The response to exogenous cofactors implies an unusually permeable cytoplasmic membrane.
Growth and Multiplication:
· Rickettsia normally multiply by transverse binary fission.
· Under poor nutritional conditions:
v The rickettsia cease dividing and grow into long filamentous forms, which subsequently undergo rapid and multiple division into the typical short rod forms when fresh nutrient is added.
v Immediately after division, the rickettsia engage in extensive movements through the cytoplasm of the cell.
v Six to ten daughter cells will form in a host cell before the cell ruptures and releases them.
· C. burnetii differs from other rickettsia in that it is enclosed in a persistent vacuole during growth and division.
Pathogenicity:
· In their arthropod vectors, the rickettsia multiply in the epithelium of the intestinal tract so they are excreted in the feces, but occasionally gain access to the arthropods salivary glands.
· They are transmitted to man by the arthropod saliva, through a bite.
· In their mammalian host, they are found principally in the endothelium of the small blood vessels, particularly in those of the brain, skin and heart.
· Hyperplasia of endothelial cells and localized thrombus (تجلط دموى) formation lead to obstruction انسداد او اعاقه of blood flow, with escape of RBC's into the surrounding tissue.
· Inflammatory cells خلايا ملتهبه also accumulate about affected segments of blood vessels. This angiitis _التهاب وعائى _appears to account for some of the more prominent clinical manifestations مظاهر
· Death is ascribed to damage of endothelial cells, resulting in leakage of plasma, decrease in blood volume, and shock.
· It is assumed that the observed clinical manifestations of a rickettsial infection are due to production of an endotoxin, this endotoxin is quite different in physiological effects from that produced by members of the Enterobacteriaceae.
·
This is inferred, although the toxin has not been isolated, from these facts:
1. IV-injected rickettsia cause rapid death in experimental animals.
2. UV-irradiation of rickettsia diminished their infectivity without reducing toxicity.
3. The use of anti-rickettsial drugs does not prevent rapid death in experimental animals.
4. Antiserum specific for cell wall antigens of the rickettsia prevents the toxic effect.


Laboratory Diagnosis:
· Presumptive laboratory diagnosis is based on the finding of rickettsial-like organisms in tissue or blood.
· Although the organisms are gram-negative, they only weakly take the counter stain; so special staining procedures are used.

Infected tissue may be stained with:
ü Macchiavello stain:
organisms are bright red against the blue background of the tissue.
ü Castaneda stain:
blue organisms against a red background.
ü Giemsa stain:
bluish purple organisms.
· Confirmative diagnosis is based on a serological reaction (Weil-Felix reaction) in which the titer of the agglutinins in the patient's serum against the Proteus strains OX-19, OX-2 and OX-K are determined.
· These Proteus strains have no etiological role in rickettsial infections, but appear to share antigens in common with certain rickettsia.
· These antigens are alkali stable polysaccharide haptens which are distinct from the group-specific and type-specific antigens.
· In interpreting the results, it must be kept in mind that Proteus infections are fairly common (especially in the urinary tract) and that they, may evoke antibodies to the Proteus-OX strains.
· This test is usually positive seven days after the initial infection.
· A more specific complement fixation test is available but does not show positive results until 14 days into the infection.
· The indirect fluorescent antibody test is also useful for the detection of IgM and IgG antibodies against rickettsia. In fact, this is the diagnostic test of choice for ehrlichiosis.
Diseases:
The rickettsial diseases of man are usually broken down according to the arthropod vector as seen in table below.





Disease
Causal agent
Animal reservoir
Weil-Felix response
1. Louse-borne



European epidemic typhus
Rickettsia prowazekii
-------------------------------------------
OX-19
Brill's disease
Rickettsia prowazekii
-------------------------------------------
Negative
Trench fever
Bartonella quintana
-------------------------------------------
Negative
2. Flea-borne



Endemic murine typhus
Rickettsia typhi
Wild rodents
OX-19
Cat scratch fever/Bacilliary angiomatosis
Bartonella henselae
Domestic cat
Unknown
3. Mite-borne



Scrub typhus
Rickettsia tsutsugamushi
Wild rodents
OX-K
Rickettsialpox
Rickettsia akari
House mice
Negative
4. Tick-borne



Rocky Mountain Spottedfever
Rickettsia rickettsii
Dog, rodents
OX-19, OX-2
North Asian tick typhus
Rickettsia siberica
Wild rodents
OX-19, OX-2
Fievre boutonneuse
Rickettsia conorii
Dog, rodents
OX-19, OX-2
Queensland tick typhus
Rickettsia australis
Marsupials, rodents
OX-19, OX-2
Q-fever
Coxiella burnetii
Cattle, sheep, goats
Negative
Spotted fever
Rickettsia rhipicephali
Dogs
Unknown
Ehrlichiosis
Ehrlichia canis
Dogs
Negative
Ehrlichiosis
Ehrlichia chaffeensis
Dogs
Negative
5. Fly-borne



Oroyo fever/Verruga peruana
Bartonella bacilliformis

Unknown
Chemotherapy:
The drugs of choice for the treatment of rickettsial diseases are chloramphenicol and tetracycline. Each of these is highly toxic, especially in children, and must be used with care. The sulfonamides stimulate rickettsial growth and thus are contraindicated in the treatment of these diseases.

Taxonomy:
· The genus Rickettsia is included in the bacterial tribe Rickettsieae, family Rickettsiaceae, and order Rickettsiales.
· This genus includes many other species of bacteria associated with human disease, including those in the spotted fever group and the typhus group
:



Spotted Fever Group (SFG):
• Rickettsia rickettsii is the cause of Rocky Mountain spotted fever (RMSF)
• Rickettsia rickettsii is found in the Americas and is transmitted to humans through the bite of infected ticks.
• Other spotted fever group rickettsiae include:
R. akari (rickettsial pox), R. japonica (Japanese
spotted fever), R. sibirica (North Asian tick typhus), tick bite fever), R. helvetica (perimyocarditis), R. australis
(Queensland tick typhus) and R. honei (Flinders Island spotted fever).
• The spotted fever rickettsiae have been found on every continent except Antarctica.
Typhus Group (TG):
• Rickettsia prowazekii is the cause of epidemic or louse-borne typhus
• R. prowazekii infects human vascular endothelial cells, producing widespread vasculitis.
• Infection usually is transmitted from person to person by the body louse and, therefore, tends to manifest under conditions of crowding and poor hygiene.
• Other rickettsiae in the typhus group include R. typhi and R. felis.
• Murine typhus is caused by transmission of R. typhi from rats, cats and opossums to humans via a flea vector.
• Murine typhus is found worldwide and is endemic to areas of Texas and southern California in the United States.
Scrub Typhus Group (STG) :
• R. tsutsugamushi is the cause of scrub typhus.
• Originally called Rickettsia tsutsugamushi, this organism was given its own genus designation because it is phylogenetically distinct from the other rickettsiae, though closely related. Orientia tsutsugamushi is transmitted to humans by the bite of trombiculid mites (chiggers), which are the vector and host.
• Scrub typhus occurs throughout much of Asia and Australia.
Summary
1. The rickettsia are extremely small gram-negative rod-shaped, coccoid or pleomorphic bacteria with limited metabolic capabilities.
2. The Family Rickettsiaceae contains three genera: Rickettsia, Ehrlichia, and Coxiella.
3. All of the members of the Family Rickettsiaceae are obligate intracellular parasites due to a highly permeable cytoplasmic membrane.
4. Confirmative diagnosis of rickettsial diseases is accomplished via the Weil-Felix test, a complement fixation test and/or an indirect fluorescent antibody test.
5. The drugs of choice for the treatment of rickettsial diseases are chloramphenicol and tetracycline.
6. Louse-borne rickettsial diseases include European epidemic typhus, and Brill's disease. Man is the sole reservoir for louse-borne diseases.
7. The only flea-borne rickettsial disease is endemic murine typhus.
8. Mite-borne rickettsial diseases include scrub typhus and rickettsialpox.
9. Tick-borne rickettsial diseases include Rocky Mountain spotted fever, North Asian tick typhus, Fievre boutonneuse.10. The major target tissue of the rickettsia is vascular endothelium.

Best wishes
Prof. Dr. F. A. Mansour





The Mycoplasma

The Mycoplasma
General Characteristics

· The mycoplasmas are essentially bacteria lacking a rigid cell wall during their entire life cycle, although they are also much smaller than bacteria.
· The first organism of this type was associated with pleuropneumonia of cattle, and was originally called the pleuropneumonia organism (PPO).
· Since that time, a number of organisms with similar morphological characteristics and cultural properties have been isolated. These are commonly referred to as pleuropneumonia-like organisms or PPLO.
· A certain group of mycoplasmas produce extremely tiny colonies on agar plates, and are called the T-strains.
· Some bacteria readily give rise spontaneously to variants that can replicate in the form of small filterable protoplasmic elements with defective or absent cell walls. These organisms, called L-forms, can also be formed by many species when cell wall synthesis is impaired by antibiotic treatment or high salt concentration.
· These organisms differ from mycoplasma in that they contain a rigid cell wall, at least at one stage of their life cycle and contain no sterols in their cytoplasmic membrane.
· These organisms are the smallest known free-living organisms.
· Because of the absence of cell walls, they do not stain with the Gram stain, and they are more pleomorphic and plastic than eubacteria.
· With Giemsa stain, they appear as tiny pleomorphic cocci, short rods, short spirals, and sometimes as hollow ring forms.
· Their diameter ranges from 0.15 u to 0.30 u.
· Most mycoplasmas require a rich medium containing a sterol and serum proteins for growth. Despite the lack of a cell wall, they do not require a medium of very high osmotic pressure.
· On solid media, they form minute, transparent colonies.
· When viewed under low-power magnification, the colony looks like a fried egg.
· The different strains vary in their growth rate and may take from two days to several weeks to form a colony.
Structure:
· The cell is enclosed by a limiting membrane which is more similar to that of animal cells than that of bacterial cells because of sterols present in the membrane.
· The cytoplasm contains ribosomes, but lacks mesosomes.
· There is no nuclear membrane.
· In some strains, amorphous material on the outer surface of the membrane suggests the existence of a capsule.
Metabolism :
· The parasitic mycoplasmas have truncated respiratory systems, lacking quinones and cytochromes.
· Another indication for the simplicity of the electron transport chain is the finding that the reduced nicotinamide adenine dinucleotide (NADH) oxidase activity is cytoplasmic.
· Complex electron transport chains are usually membrane bound, since they depend on the spatial organization of their components.
· Ruling out oxidative phosphorylation as an ATP-generating system leaves only two proven ways of ATP generation, both based on substrate level phosphorylation. The major source for ATP is the arginine dihydrolase pathway.
arginine deaminaseArginine + H2O --------------------------------> citrulline + NH3 ornithine carbamoyltransferaseCitrulline+inorganic orthophosphate------>ornithine+carbamoylPO
Carbamate kinaseCarbamoyl PO4 + ADP --------------------------> ATP + CO2 + NH3
Another mechanism for ATP generation is:
Phosphate acetyltransferaseAcetyl CoA + inorganic orthophosphate -----------------> acetyl PO4 + CoA
Acetate kinaseAcetyl PO4+ ADP ------------------------------------> Acetate + ATP

Multiplication:
· In the absence of a rigid cell wall, the pattern of replication is quite different from that of typical bacteria, whose division starts with the formation of a well-defined septum.
· Though the mechanism of division in mycoplasmas is controversial, sequential microscopic observation suggests that new elementary particles arise by fragmentation of filamentous cells containing several discrete DNA components.



Pathogenesis:
· M. pneumoniae is an extracellular pathogen that adheres to the respiratory epithelium by a specialized terminal protein attachment factor.
· This adherence protein interacts specifically with neuraminic acid residues on the epithelial cell surface.
· Ciliastasis occurs following attachment and then destruction of the superficial layer of epithelial cells. Destruction is due to release of hydrogen peroxide and superoxide anion.
Diseases:
The human diseases caused by mycoplasmas are shown in the table below.
Disease or symptom
Agent
Host
Primary atypical pneumonia
Mycoplasma pneumoniae
Man
Non-gonococcal urethritis (NGU)
Mycoplasma genitalium
Man
NGU
Ureaplasma urealyticum
Man
Stillbirth
Mycoplasma hominis
Man
Spontaneous abortion
Mycoplasma hominis
Man
Infertility
Mycoplasma hominis
Man
Laboratory Diagnosis :
The laboratory diagnosis of mycoplasma infection can be accomplished by:
1. Culturing the organism from sputum, mucous membrane swabbings or other specimens by direct inoculation into liquid or solid media containing serum, yeast extract and penicillin to inhibit contaminating bacteria. Colonies will become detectable in one to three weeks. They stain intensely with neutral red or tetrazolium or methylene blue. The organism can be presumptively identified by its hemabsorption or B-hemolysis of guinea pig red blood cells. It is conclusively identified by staining its colonies with homologous fluorescein-labelled antibody.
2. Quantitation of the patient antibody response to mycoplasma by complement fixation tests on acute and convalescent serum. Cold agglutinins to human O erythrocytes may also be
measuredChemotherapy:
Primary atypical pneumonia is usually selflimiting and does not require antibiotic treatment. However, if antibiotics are needed, the drug of choice is one of the macrolide antibiotics:
Azithromycin Clarithromycin Dirithromycin Erythromycin
Urogenital diseases may be treated with:
Metronidazole (except during the first trimester of pregnancy) Clindamycin

1. The mycoplasma is extremely small free-living bacteria which lack a cell wall and cytochromes.
2. Mycoplasma can be cultured on agar media but colonies take up to three weeks to develop.
3. Serological identification of mycoplasma disease relies upon the quantitation of cold agglutinins to human O erythrocytes or a complement fixation test or serum inhibition of mycoplasma growth.
4. Human diseases of mycoplasma etiology are primary atypical pneumonia, non-gonococcal urethritis, stillbirth, spontaneous abortion and infertility.

Best wishes
Prof. Dr. Fathi Awwad Mansour

Chlamydia


Organism:
Genus: Chlamydia
Species: trachomatis, psittaci

General Characteristics of Chlamydia :
The chlamydia, which are incorrectly called the PLT viruses or Bedsonia or basophilic viruses, are bacteria which are obligate intracellular parasites of higher animals (mammals and birds).
The members of this group share a unique development cycle, a common morphology and a common family antigen.
They are not transmitted by arthropods.
These organisms are termed basophilic because they take up the Giemsa stain (i.e., they stain blue).
They are gram-negative, non-motile and multiply in the cytoplasm of the host cell.
These organisms generally parasitize epithelial cells.
The methods used to study them are, in the main, those of the virologist rather than the bacteriologist.
Furthermore, the clinical features, pathogenesis, pathology and epidemiology of chlamydial infections are similar to those of viral infections.
Distinctive properties:
The Chlamydia have an unusual developmental cycle that involves two distinct forms: infectious elementary bodies & intracellular reticulate bodies
Elementary bodies attach and are internalized by susceptible host cells. Once inside, they reorganize into a replicative form (the reticulate body).
Over a 24 hour period, these reticulate bodies divide and begin to reorganize back into elementary bodies.
About 48-72 hours after infection, the cell is lysed and numerous infectious elementary bodies are released.
The genome of Chlamydia is only 25% the size of E. coli, making it one of the smallest prokaryotes.
The pathogenic mechanisms employed by Chlamydia are not well understood.
Taxonomy of Chlamydia :
The chlamydia fall into two main ecological groups:
Group A: are the agents causing trachoma, inclusion conjunctivitis, and lymphogranuloma venereum, which seem to infect man only.
Group B: are those agents transmitted to man as zoonotic infections (mainly birds)
About 100 species of birds are naturally infected with chlamydia. This includes 71 species of parrots as well as finches, pigeons, chickens, ducks, turkeys and seabirds.

Morphology and Structure:
· The chlamydial cell is roughly spherical and measures between 0.3 and 1.0 u in diameter, according to the stage of development.
· Both the small and the large cell types contain complete cell walls which are similar to the cell walls of gram-negative bacteria.
· Under the cell wall lies a separate cytoplasmic membrane made up of large amounts of lipid. .The DNA occurs as an irregular mass in the cytoplasm.
· There is no nuclear membrane.
· Ribosomes can be seen throughout the cytoplasm.
· The cells contain no capsule or flagella.
Metabolism :
· There are no detectable flavoproteins or cytochromes.
· It appears that the basis of the obligate intracellular parasitism is due to a lack of ATP-generating ability and the need to obtain ATP from the host cell.
· The cells can synthesize DNA, RNA and protein.
Growth and multiplication :
Chlamydia passes through a series of developmental forms while multiplying by binary fission.
This is termed the "developmental cycle." Two morphologically different developmental forms with a continuous gradation of intermediates between them can be recognized.
One is a small cell about 0.3 u in diameter, with an electron-dense nucleoid.
The other is a large cell, 0.5 to 1.0 u in diameter without a dense center.
There appears to be no significant difference in morphology or developmental cycle among the various chlamydia, and a single generalized description applies to all.
The development cycle may be regarded as an orderly alternation of the small and large cell type.
It is initiated by the highly infectious small cell which is taken into the host cell by phagocytosis.
The engulfed small cell retains its morphological integrity in vacuoles bound by membrane derived from the surface of the host cell, and there is no eclipse (period in which the parasite loses the infectious ability).
Without loss of individuality, the small cell is reorganized into a large cell which is the vegetative multiplying form of these organisms.
Then, still in the membrane-bound vacuole, the large cell grows in size and multiplies by repeated binary fission.
The developmental cycle is completed by the reorganization of most of the large cells into small ones which are then available for infection of new host cells.
The time required for completion of a cycle varies from 24-48 hours, depending on the particular host/parasite system involved.
ELEMENTARY BODY (EB) .
RETICULATE BODY (RB) .
Cell size 0.3 um in diameter.
Size 0.5 - 1.0 um in diameter.
RNA : DNA content = 1.1
RNA : DNA content = 3.1
Infectious
Not infectious
Adapted for extracellular survival
Adapted for intracellular growth
Hemagglutinin present
Hemagglutinin absent
Induces endocytosis
Does not induce endocytosis
Metabolically inactive
Metabolically active
Characteristics of the elementary and reticulate bodies of Chlamydia can be found in the table below.
Pathogenicity :
Sub group A organisms, primarily infect the mucous membranes of the eye or the genitourinary tract of humans.
Sub group B organisms
, although primarily parasites of birds can be transmitted to man where they cause a lung infection.
The mechanism by which chlamydia cause disease or injure cells is unknown.
Chlamydial infections of mucous membranes cause damage to tissues deep in the epithelial layer; for example, in trachoma, scarring of the tarsal plate occurs frequently.
There is some evidence that a toxin is produced.
Epidemiology:
Trachoma is prevalent in Africa and Asia, generally in hot and dry areas.
The organisms are very persistent. Their habitat is similar to that of Neisseria and Haemophilus.
Infection can occur via swimming in unchlorinated pools, sharing towels or by passage through the birth canal.

Laboratory Diagnosis :
Laboratory diagnosis is made by one or more of the following:
1. Isolation of the organism from infected tissue:
The tissue is inoculated into the yolk sac of seven-day chick embryos or in McCoy human cells.
2. Characteristic cytoplasmic inclusion bodies infected cells.
3. Serological diagnosis:
a. Microimmunofluorescent tests in tears of patients with eye infections for the presence of anti-chlamydia antibody. In neonatal conjunctivitis and early trachoma, direct immunofluorescence of conjunctive cells with fluorescein - conjugated monoclonal antibody is sensitive and specific.
b. Delayed-type skin reaction (type IV hypersensitivity) to killed organisms in genitourinary infections (Frei test).
c. Rising titer of antibody against the chlamydial family antigen in lung infecitons. This accomplished with the complement fixation test or the fluorescent antibody test.


Treatment :
Chlamydia exhibit low pathogenicity except in a compromised host. The chlamydial diseases are relatively easy to treat, but present two problems.
1. Latency of infection:infections may remain latent or sub-clinical for years.
2. Susceptibility of compromised host to reinfection:
the compromised host usually remains compromised because of genetic and/or environmental factors and becomes reinfected.
3. Minimal symptomology :
Chlamydia trachomatis - doxycycline or azithromycinChlamydia pneumonia - doxycycline or azithromycin or erythromycinChlamydia psittaci - doxycycline or erythromycin
Diseases:
The chlamydial diseases include: Chlamydia has on its surface, a peptide that resembles one in heart myosin.
The peptide, when displayed by antigen-presenting cells, can trigger T-cells that attack both Chlamydia and heart cells, thus causing heart muscle inflammation (myocarditis).
This autoimmune reaction also plays a role in the formation of the artery-clogging plaques of atherosclerosis.
Chlamydia induce interferon and are sensitive to it.

Subgroup A Diseases (Persn to person transmition ) :
Trachoma :
Causual agent : Chlamydia trachomitis
host : Man
Subgroup A (person-to-person transmition)
Inclusion conjunctivitis :
Causative agent: Chlamydia trachomitis
Host : Fowl, Man
Urethritis :
Host :Man
Causative agent: Chlamydia trachomatis
Cervicitis :
Causative agent :Chlamydia trachomatis
Host :Man
Ophthalmia neonatorum :
Causativ agent :Chlamydia trachomatis
Host :Man
Myocarditis :
Causative agent :Chlamydia trachomatis
Host : Man
Lymphogranuloma venereum :
Causative agent : Chlamydia trachomatis
Host : Man
Atherosclerosis :
Causative agent : Chlamydia trachomatis
Host :Man
Neonatal Pneumonia :
Causative agent :Chlamydia trachomatis
Host : Man

Subgroup B (mostly bird-to-human (transmition) :
Bronchitis/pneumonia/sinusitis :
Causative agent : Chlamydia pneumoniae
Host : Man
Atherosclerosis :
Causative agent : Chlamydia pneumoniae
Host : Man
Meningopneumonitis :
Causative agent : Chlamydia psittaci
Birds --> Man
Hepatic and renal dysfunction :
Chlamydia psittaci
Birds --> Man
Conjunctivitis :
Chlamydia psittaci
Birds --> Man
Abortion :
Chlamydia psittaci
Birds --> Man
Endocarditis :
Chlamydia psittaci
Birds --> Man
During infection, antibodies are synthesized but recovery is not generally protective.
CONTROL:
Sanitary: Good hygiene, treatment of sexual partners and the quarantine of birds all reduce the incidence.
Immunological: No vaccine is available or likely since specific antibodies fail to neutralize elementary bodies in vivo.
Chemotherapeutic: Tetracycline or erythromycin are drugs of choice.
Summary :
1. The chlamydia are extremely small, gram-negative, coccal-shaped, obligate intracellular parasites with limited metabolic capability which are classified as bacteria.
2. The chlamydia lack flavoproteins and cytochromes.
3. Chlamydia undergo a unique developmental cycle which is an alternation in size between the small elementary body and the relatively large reticulate body.
4. The elementary body is relatively metabolically inactive, adapted for extracellular survival and is the infectious unit.
5. The reticulate body is metabolically active, adapted for intracellular growth and is not infectious.
6. The major target tissue of the chlamydia is mucous membranes.
7. Serological diagnosis of chlamydial diseases is via a fluorescent antibody test, complement fixation test or a delayed type hypersensitivity test (Frei test) for lymphogranuloma venereum.

Best wishes
Prof.Dr. Fathi Awwad Mansour






الأحد، 22 مارس 2009


Prof. Fathy Awwad Aly Mansour
Professor of bacteriology and Applied Microbiology, Botany Department
Faculty of Science, Mansoura University, Mansoura, Egypt.

Name : Fathy Awwad Aly Mansour

Nationalty : Egyptian

Date of Birth : 25 th July, l942

Marital Status: Married

Place of Birth : El-Geza, Egypt.

Personal Data

· Scientific Qualifications

· B.Sc. in Chemistry and Botany, Faculty of Science, Cairo University (l965)

· M.Sc. (Microbiology), Faculty of Science, Cairo University (1972)

· Ph.D. (Microbiology), Faculty of Science, Mansoura University (1977)

· Academic Appointments

· Assistant Lecturer in Microbiology, Department of Botany, Faculty of Science, Mansoura University (From 20/5/ l 974 to 30/7/1977)

· Lecturer in Microbiology, Department of Botany, Faculty of Science, Mansoura University (From 31/7/1977 to 6/9/1981)

· Assistant Professor of Microbiology, Department of Botany, Faculty of Science, Mansoura University (From 7/9/1981 to 1/12/1985).

· Professor of Bacteriology and Applied Microbiology, Department of Botany, Faculty of Science , Mansoura University (From 2/12/1985 to present).

· Head of Botany Department, Faculty of Sciece Mansoura University (From 16/91991 to 15/9/ 1997,

· Chairman of the Unit of Microbiological Analyses, Faculty of Science, Mansoura University (From 9/5/1990 to 15/10/2005).

· Scientific Activities

A. Post-Doctoral Fellowship:
· I worked as a research-fellow in the Laboratory of Microbiology at the Department of Botany, University of Liverpool, England, in collaboration with Prof. Dr. S.T. Williams and Prof. Dr. M. Goodfellow (From 24/9/l98l to 13/9/1982). The main object of the work was aiming at the isolation of bacteriophage, studying their host-range specificity and the possibility of their implication in the
identification of bacteria
.
B. School of Microbiology
It is my great honor to be the man who initiated the researches in the fields of environmental and applied microbiology, taxonomy and physiology of bacteria in the Faculty of Science, Mansoura University. Under my supervision, many research students (in the Faculties of Science at Mansoura, Damietta, Benha, and Zagazig) got M.Sc. and Ph.D. degrees in the different areas of microbiology.
C. Academic activities
Supervisor of Microbiology Unit, Fac. Sci. Mansoura Univ. From 18/ 9/ 2005 to present.

Chairman of training program on Microbilogical Analysis held in Fac. Sci. Mansoura Univ. from 20 – 24/ 11/ 2005.
Chairman of training program on Applied Microbiology held in Fac. Sci. Mansoura Univ. From 26 – 28/ 2/ 2006.

· Conferences

I had attended several international, regional and local scientific conferences in e.g. Tunis (1978), Cairo (1979), Florida, U.S.A. (1980), Mansoura (1982, 1983, 1985 -1987& 2008), Ismailia (1985-2005-2006-2007-2008) Cairo( 1995-1997-1999-2001&2003),Tanta (2003-2005-2007-& 2009) . Zagazig ( 1996-1998-2002-2004-2006 &2008 ) . In all of these meetings I presented papers including the results of my studies:( see the list of publications) or acting as a chairman of scientific sessions.

· Prizes
Mansoura University Evaluation Prize in 2005.Address: Department of Botany, Faculty of Science, Mansoura University Mansoura, Egypt. Telephone: 050/352388Telefax 095-20-50-347900 Telex 23768 MANU UN.
· How To Contact
Address
Dept. of Botany , Faculty of Science, Mansoura University, Mansoura, Egypt.

Phone

Mobile : +0124459685, 0161887716
Tel.home :+20-50-2242388